N-Terminal Atrial Natriuretic Peptide Precursor Detection Reagent(NT-ProBNP) (Immunofluorescence Chromatography)
NT-proBNP Overview
N-terminal pro atrial natriuretic peptide (NT proBNP) is a peptide hormone secreted by the heart. It is an important regulatory factor in the pathology and physiology of heart failure. It has high value in the diagnosis and prognosis of heart failure. It is recommended by ACC / AHA, ESC and guidelines for the diagnosis and treatment of heart failure.
NT-proBNP Performance Index
| Detection range | sample size | Sample type | Test time |
| 80~20000pg/mL | 60μl | Whole blood / serum / plasma | 15min |
NT-proBNP Clinical significance
- Early diagnosis of heart failure and risk stratification
- To evaluate and monitor the prognosis of heart failure
- Distinguish between heart failure and dyspnea caused by other causes
- Auxiliary ACS risk stratification
- High risk population screening
| Acute heart failure |
| Age | NT-proBNP(pg/ml) | Diagnosis of heart failure |
| It's not about age | <300 | Eliminate the possibility of heart failure |
| < 50 years old | 300-450 | The possibility of heart failure is low, combined with other clinical manifestations |
| 50-75 years old | ≧450 |
High risk of heart failure |
| 300-900 | The possibility of heart failure is low, combined with other clinical manifestations |
| ≧900 | High risk of heart failure |
| >75 years old | 300-1800 | The possibility of heart failure is low, combined with other clinical manifestations |
| ≧1800 | High risk of heart failure |
| Chronic heart failure |
| It's not about age | <400 | Eliminate heart failure |
| | 400- 2000 | The clinical manifestations, ECG, chest X-ray and CT should be collected Differential diagnosis of multiple indexes by echocardiography |
| | ≧2000 | High risk of heart failure |
Application Department
Cardiology, emergency, ICU, respiratory, laboratory, surgery, neurology, obstetrics and Gynecology, oncology, etc
NT-proBNP Clinical comparison
Company profile
Zhongxiu Science And Technology Co.,Ltd., is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, microbial series, biochemical series and immune series reagents and supporting instruments.
The company has always adhered to the core concept of "fast and accurate, living up to life", committed to providing society with excellent products and services, and contributing to the cause of human health.
